AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TACROLIMUS USP
8 registrations across 3 African markets— 8 active
Markets with TACROLIMUS USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Tacrocord 1 Capsules | 🇷🇼Rwanda | Concord Biotech Limited | active | Oct 2030 |
| REMUS 0.1% OINTMENT Ointment | 🇰🇪Kenya | Square Pharmaceuticals Limited | active | Oct 2030 |
| Tacrocord 0.5 Capsule, Hard | 🇰🇪Kenya | CONCORD BIOTECH LIMITED | active | Jan 2027 |
| Tacrocord 5 Capsule, Hard | 🇰🇪Kenya | CONCORD BIOTECH LIMITED | active | Aug 2026 |
| TACROLIMUS USP TOPICAL EXTERNAL
OINTMENTS | 🇺🇬Uganda | GLENMARK PHARMACEUTICA L LTD | active | — |
| TACROLIMUS USP TOPICAL
EXTERNAL
OINTMENTS | 🇺🇬Uganda | GLENMARK PHARMACEUTICA L LTD | active | — |
| TACROLIMUS USP TOPICAL EXTERNAL
OINTMENTS | 🇺🇬Uganda | GLENMARK PHARMACEUTICA L LTD | active | — |
| TACROLIMUS USP TOPICAL
EXTERNAL
OINTMENTS | 🇺🇬Uganda | GLENMARK PHARMACEUTICA L LTD | active | — |
TACROLIMUS USP in Africa — Regulatory Overview
TACROLIMUS USP is registered across 3 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Kenya, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 8 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.